BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Friday, April 19, 2024
Home
»
Newsletters
» BioWorld
BioWorld
Jan. 28, 2009
View Archived Issues
CVT Rejects $1B Acquisition Offer from Partner Astellas
Astellas Pharma Inc. revealed Tuesday that it has spent the last year attempting to acquire CV Therapeutics Inc., but the biotech rejected its latest $1 billion offer and declined to engage in further discussions. (BioWorld Today)
Read More
Theravance Files Telavancin NDA for Hospital-Acquired Pneumonia
Read More
Obama Election Called End of 'Sad Chapter' for Science
Read More
Mixed Bag of Pipeline News for Amgen as Earnings Fall Short
Read More
Drugmakers Slow to Personalized Medicine Risk Market Share
Read More
UK Report on Start-ups Calls for New Source of Funding
Read More
NitroMed Agrees to Deerfield Sale, but also Vows to Shop Around
Read More
Other News To Note
Read More
Clinic Roundup
Read More